On the other hand, SEGA patients may have two independent inactivating somatic mutations in TSC1 or TSC2, and thereby, both copies of the TSC1 or TSC2 gene are lost in the cells that form the tumor, but the mutations in other patients’ cells are absent [6]. This evidence concerns the gene TSC2 and neoplasm.